Xiaoshan Wang

Title: The Innovations of Xiaoshan Wang

Introduction

Xiaoshan Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of coagulation factor VIII fusion proteins. His innovative work has the potential to improve treatments for hemophilia and other bleeding disorders.

Latest Patents

Xiaoshan Wang holds a patent for an FVIII fusion protein and its use. This invention discloses a coagulation factor VIII fusion protein that is conjugated with polyalkylene glycol, resulting in an extended cyclic half-life. The active moiety of the coagulation factor VIII is linked to a fusion partner, either directly or indirectly via a peptide linker. This innovative fusion protein demonstrates a significantly increased half-life compared to FVIII fusion proteins modified without polyalkylene glycol. He has 1 patent to his name.

Career Highlights

Xiaoshan Wang is currently employed at Zhengzhou Gensciences Inc., where he continues to advance his research in biotechnology. His work focuses on enhancing the efficacy and safety of therapeutic proteins, which can lead to better patient outcomes.

Collaborations

Xiaoshan has collaborated with notable colleagues, including Hongsheng Su and Yu Wang. Their combined expertise contributes to the innovative research and development efforts at their company.

Conclusion

Xiaoshan Wang's contributions to the field of biotechnology, particularly through his patented FVIII fusion protein, highlight his role as a leading inventor. His work not only showcases his innovative spirit but also has the potential to significantly impact medical treatments for patients with bleeding disorders.